Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Continuous Standard Bupivacaine Versus Single Liposomal Bupivacaine Injection for Interscalene Brachial Plexus Block for Pain Management After Proximal Humerus Fracture Fixation

NCT04928664 is registered in ClinicalTrials.gov with The University of Hong Kong as lead sponsor.

NCT NCT04928664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04928664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Continuous Standard Bupivacaine Versus Single Liposomal Bupivacaine Injection for Interscalene Brachial Plexus Block for Pain Management After Proximal Humerus Fracture Fixation
Lead sponsor
The University of Hong Kong
Phase
Phase 4
Overall status
Completed
Start date
September 9, 2020
Completion date
March 5, 2026
Enrollment
78 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

shoulder fractures